Literature DB >> 35228935

Primary Pleomorphic Omental Rhabdomyosarcoma in an Adult: A Report of a Unique Case.

Ilham A Alteerah1, Raouf H Azzuz2, Mohamed A Moftah3, Yousef M Hasen4, Soad I Eldruki5.   

Abstract

Rhabdomyosarcoma (RMS) is a very rare, highly malignant neoplasm thought to originate from the pluripotent mesenchymal tissue. Predominantly diagnosed among children and teenagers, however they can also be encountered in adults. There are a few risk factors associated with RMS like family history of malignancy and genetic syndromes like neurofibromatosis type 1, Li-Fraumeni syndrome, Noonan syndrome and Beckwith-Wiedemann syndrome; however, most cases of RMS are sporadic. Other factors like radiotherapy for other malignancy and pre-natal radiation exposure also are associated with increased risk of developing RMS. The most common reported sites for RMS are head, neck, trunk, pelvis and lower limbs. Omental involvement of primary RMS has been rarely reported in the literature. Principally, the survival of treated RMS cases has improved, primarily due to multidisciplinary management approaches. In this paper, we report a case of primary pleomorphic RMS in a 50-year-old female who presented with abdominal pain.
Copyright © 2022, Alteerah et al.

Entities:  

Keywords:  chemotherapy; omentum; pleomorphic rhabdomyosarcoma; primary rhabdomyosarcoma; radiotherapy

Year:  2022        PMID: 35228935      PMCID: PMC8873375          DOI: 10.7759/cureus.21576

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  16 in total

Review 1.  Pleomorphic Rhabdomyosarcoma of the Uterus - Case Report and a Systematic Review of the Literature.

Authors:  Sara Alavi; Lena Eckes; Robert Kratschell; Eliane Tabea Taube; Friederike Rosseck; Gero Wieners; Jalid Sehouli
Journal:  Anticancer Res       Date:  2017-05       Impact factor: 2.480

2.  Rhabdomyosarcoma disease spread evaluation on CT scans: Association with primary tumor size and Ki-67 proliferation marker.

Authors:  Shelly Soffer; Marianne Michal Amitai; Orit Shimon; Orly Ohana; Noa Rozendorn; Iris Barshack; Rony Weitzen; Eyal Klang
Journal:  Clin Imaging       Date:  2019-02-12       Impact factor: 1.605

Review 3.  Rhabdomyosarcomas in adults and children: an update.

Authors:  David M Parham; Dale A Ellison
Journal:  Arch Pathol Lab Med       Date:  2006-10       Impact factor: 5.534

4.  Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: an analysis of 2,600 patients.

Authors:  Iyad Sultan; Ibrahim Qaddoumi; Sameer Yaser; Carlos Rodriguez-Galindo; Andrea Ferrari
Journal:  J Clin Oncol       Date:  2009-04-27       Impact factor: 44.544

5.  Pleomorphic rhabdomyosarcoma of the liver in an adult: a rare case report.

Authors:  Mitsuyoshi Okazaki; Hidehiro Tajima; Yoshinao Ohbatake; Hiroyuki Shinbashi; Shinichi Nakanuma; Isamu Makino; Itasu Ninomiya; Sachio Fushida; Koushiro Ohtsubo; Tetsuo Ohta
Journal:  BMC Surg       Date:  2020-04-21       Impact factor: 2.102

6.  Characteristics and prognosis of embryonal rhabdomyosarcoma in children and adolescents: An analysis of 464 cases from the SEER database.

Authors:  Xinyu Wang; Jun Feng; Zhe Li; Xin Zhang; Jun Chen; Guoshuang Feng
Journal:  Pediatr Investig       Date:  2020-12-28

7.  Omental rhabdomyosarcoma (primary rhabdoid tumor of greater omentum): a rare case report.

Authors:  Priyank Pathak; Mayank Nautiyal; P K Sachan; Nadia Shirazi
Journal:  Surg Case Rep       Date:  2015-09-02

8.  Primary Mesenteric Undifferentiated Pleomorphic Sarcoma Masquerading as a Colon Carcinoma: A Case Report and Review of the Literature.

Authors:  Robert Diaz-Beveridge; Marcos Melian; Carlos Zac; Edwin Navarro; Dilara Akhoundova; Melitina Chrivella; Jorge Aparicio
Journal:  Case Rep Oncol Med       Date:  2015-08-26

Review 9.  Pleomorphic rhabdomyosarcoma of the liver with a hepatic cyst in an adult: Case report and literature review.

Authors:  Jingyang Yin; Zuojin Liu; Kang Yang
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.